Loading...
KORU Medical Systems, Inc.
KRMD•NASDAQ
Healthcare
Medical - Instruments & Supplies
$3.41
$-0.05(-1.45%)
KORU Medical Systems, Inc. (KRMD) Financial Performance & Income Statement Overview
Review KORU Medical Systems, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.98%
↑ 17.98%
Operating Income Growth
37.23%
↑ 37.23%
Net Income Growth
55.85%
↑ 55.85%
Operating Cash Flow Growth
93.47%
↑ 93.47%
Operating Margin
-15.71%
↓ 15.71%
Gross Margin
63.49%
↑ 63.49%
Net Profit Margin
-15.10%
↓ 15.10%
ROE
-30.44%
↓ 30.44%
ROIC
-28.39%
↓ 28.39%
KORU Medical Systems, Inc. (KRMD) Income Statement & Financial Overview
Review KORU Medical Systems, Inc.'s (KRMD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.84M | $8.18M | $8.43M | $8.20M |
| Cost of Revenue | $3.28M | $2.99M | $2.95M | $3.33M |
| Gross Profit | $5.56M | $5.19M | $5.48M | $4.87M |
| Gross Profit Ratio | $0.63 | $0.63 | $0.65 | $0.59 |
| R&D Expenses | $1.11M | $1.53M | $1.13M | $1.48M |
| SG&A Expenses | $5.83M | $5.13M | $5.32M | $5.36M |
| Operating Expenses | $7.15M | $6.89M | $6.45M | $6.83M |
| Total Costs & Expenses | $10.43M | $9.88M | $9.62M | $10.16M |
| Interest Income | $80459.00 | $112995.00 | $214000.00 | $37187.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $211454.00 | $227786.00 | $217864.00 | $231370.00 |
| EBITDA | -$1.35M | -$1.48M | -$974170.00 | -$1.73M |
| EBITDA Ratio | -$0.15 | -$0.18 | -$0.12 | -$0.21 |
| Operating Income | -$1.59M | -$1.70M | -$1.19M | -$1.96M |
| Operating Income Ratio | -$0.18 | -$0.21 | -$0.14 | -$0.24 |
| Other Income/Expenses (Net) | $31284.00 | $122480.00 | $203319.00 | $25408.00 |
| Income Before Tax | -$1.56M | -$1.58M | -$988715.00 | -$1.94M |
| Income Before Tax Ratio | -$0.18 | -$0.19 | -$0.12 | -$0.24 |
| Income Tax Expense | $2893.00 | $0.00 | $0.00 | $188094.00 |
| Net Income | -$1.56M | -$1.58M | -$988715.00 | -$1.94M |
| Net Income Ratio | -$0.18 | -$0.19 | -$0.12 | -$0.24 |
| EPS | -$0.03 | -$0.03 | -$0.02 | -$0.04 |
| Diluted EPS | -$0.03 | -$0.03 | -$0.02 | -$0.04 |
| Weighted Avg Shares Outstanding | $45.91M | $45.85M | $45.81M | $45.71M |
| Weighted Avg Shares Outstanding (Diluted) | $45.91M | $45.85M | $45.81M | $45.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan